SEC Comment Letter 0000000000-25-002652 to PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: March 11, 2025 · CIK: 0001985062 · Accession: 0000000000-25-002652
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285542
Letter
Re: Psyence Biomedical Ltd. Registration Statement on Form F-3 Filed March 4, 2025 File No. 333-285542 Dear Neil Maresky:
March 11, 2025
Neil Maresky Chief Executive Officer Psyence Biomedical Ltd. 121 Richmond Street West, Suite 1300 Toronto, Ontario M5H 2K1
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Ari Edelman, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 11, 2025 Neil Maresky Chief Executive Officer Psyence Biomedical Ltd. 121 Richmond Street West, Suite 1300 Toronto, Ontario M5H 2K1 Re: Psyence Biomedical Ltd. Registration Statement on Form F-3 Filed March 4, 2025 File No. 333-285542 Dear Neil Maresky: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ari Edelman, Esq. </TEXT> </DOCUMENT>